The Market Reports

Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com

Malaria Treatment-Global Market Insights and Sales Trends 2024

Malaria Treatment-Global Market Insights and Sales Trends 2024

Publishing Date : Dec, 2023

License Type :
 

Report Code : 1882129

No of Pages : 102

Ask Your Query

Synopsis

The global Malaria Treatment market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Malaria Treatment in various end use industries.

The expanding demands from the Hospital Pharmacy, Retail Pharmacy and E-Commerce,, are propelling Malaria Treatment market. Quinine, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Chloroquine segment is estimated at % CAGR for the next seven-year period.

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs.

However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Objectives

This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Malaria Treatment, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.

Key Features of The Study:

This report provides in-depth analysis of the global Malaria Treatment market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.

This report profiles key players in the global Malaria Treatment market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Malaria Treatment sales data, market share and ranking.

This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.

This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.

Key companies of Malaria Treatment covered in this report include Advanz Pharmaceutical, Ipca Laboratories Ltd, Zydus Cadila, Glenmark, Olympus Corporation, Abbott, Sanofi, GlaxoSmithKline plc. and Novartis AG, etc.

The global Malaria Treatment market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.

Market Segmentation

Company Profiles:

  • Advanz Pharmaceutical
  • Ipca Laboratories Ltd
  • Zydus Cadila
  • Glenmark
  • Olympus Corporation
  • Abbott
  • Sanofi
  • GlaxoSmithKline plc.
  • Novartis AG
  • TEVA PHARMACEUTICAL INDUSTRIES LTD

Global Malaria Treatment market, by region:

  • North America (U.S., Canada, Mexico)
  • Europe (Germany, France, UK, Italy, etc.)
  • Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
  • South America (Brazil, etc.)
  • Middle East and Africa (Turkey, GCC Countries, Africa, etc.)

Global Malaria Treatment market, Segment by Type:

  • Quinine
  • Chloroquine
  • Proguanil
  • Mefloquine
  • Pyrimethamine
  • Other

Global Malaria Treatment market, by Application

  • Hospital Pharmacy
  • Retail Pharmacy
  • E-Commerce

Core Chapters

Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Malaria Treatment companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion

Index

1 Market Overview of Malaria Treatment
1.1 Malaria Treatment Market Overview
1.1.1 Malaria Treatment Product Scope
1.1.2 Malaria Treatment Market Status and Outlook
1.2 Global Malaria Treatment Market Size Overview by Region 2018 VS 2022 VS 2029
1.3 Global Malaria Treatment Market Size by Region (2018-2029)
1.4 Global Malaria Treatment Historic Market Size by Region (2018-2023)
1.5 Global Malaria Treatment Market Size Forecast by Region (2024-2029)
1.6 Key Regions, Malaria Treatment Market Size (2018-2029)
1.6.1 North America Malaria Treatment Market Size (2018-2029)
1.6.2 Europe Malaria Treatment Market Size (2018-2029)
1.6.3 Asia-Pacific Malaria Treatment Market Size (2018-2029)
1.6.4 Latin America Malaria Treatment Market Size (2018-2029)
1.6.5 Middle East & Africa Malaria Treatment Market Size (2018-2029)
2 Malaria Treatment Market by Type
2.1 Introduction
2.1.1 Quinine
2.1.2 Chloroquine
2.1.3 Proguanil
2.1.4 Mefloquine
2.1.5 Pyrimethamine
2.1.6 Other
2.2 Global Malaria Treatment Market Size by Type: 2018 VS 2022 VS 2029
2.2.1 Global Malaria Treatment Historic Market Size by Type (2018-2023)
2.2.2 Global Malaria Treatment Forecasted Market Size by Type (2024-2029)
2.3 Key Regions Market Size by Type
2.3.1 North America Malaria Treatment Revenue Breakdown by Type (2018-2029)
2.3.2 Europe Malaria Treatment Revenue Breakdown by Type (2018-2029)
2.3.3 Asia-Pacific Malaria Treatment Revenue Breakdown by Type (2018-2029)
2.3.4 Latin America Malaria Treatment Revenue Breakdown by Type (2018-2029)
2.3.5 Middle East and Africa Malaria Treatment Revenue Breakdown by Type (2018-2029)
3 Malaria Treatment Market Overview by Application
3.1 Introduction
3.1.1 Hospital Pharmacy
3.1.2 Retail Pharmacy
3.1.3 E-Commerce
3.2 Global Malaria Treatment Market Size by Application: 2018 VS 2022 VS 2029
3.2.1 Global Malaria Treatment Historic Market Size by Application (2018-2023)
3.2.2 Global Malaria Treatment Forecasted Market Size by Application (2024-2029)
3.3 Key Regions Market Size by Application
3.3.1 North America Malaria Treatment Revenue Breakdown by Application (2018-2029)
3.3.2 Europe Malaria Treatment Revenue Breakdown by Application (2018-2029)
3.3.3 Asia-Pacific Malaria Treatment Revenue Breakdown by Application (2018-2029)
3.3.4 Latin America Malaria Treatment Revenue Breakdown by Application (2018-2029)
3.3.5 Middle East and Africa Malaria Treatment Revenue Breakdown by Application (2018-2029)
4 Malaria Treatment Competition Analysis by Players
4.1 Global Malaria Treatment Market Size by Players (2018-2023)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Malaria Treatment as of 2022)
4.3 Date of Key Players Enter into Malaria Treatment Market
4.4 Global Top Players Malaria Treatment Headquarters and Area Served
4.5 Key Players Malaria Treatment Product Solution and Service
4.6 Competitive Status
4.6.1 Malaria Treatment Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 Advanz Pharmaceutical
5.1.1 Advanz Pharmaceutical Profile
5.1.2 Advanz Pharmaceutical Main Business
5.1.3 Advanz Pharmaceutical Malaria Treatment Products, Services and Solutions
5.1.4 Advanz Pharmaceutical Malaria Treatment Revenue (US$ Million) & (2018-2023)
5.1.5 Advanz Pharmaceutical Recent Developments
5.2 Ipca Laboratories Ltd
5.2.1 Ipca Laboratories Ltd Profile
5.2.2 Ipca Laboratories Ltd Main Business
5.2.3 Ipca Laboratories Ltd Malaria Treatment Products, Services and Solutions
5.2.4 Ipca Laboratories Ltd Malaria Treatment Revenue (US$ Million) & (2018-2023)
5.2.5 Ipca Laboratories Ltd Recent Developments
5.3 Zydus Cadila
5.3.1 Zydus Cadila Profile
5.3.2 Zydus Cadila Main Business
5.3.3 Zydus Cadila Malaria Treatment Products, Services and Solutions
5.3.4 Zydus Cadila Malaria Treatment Revenue (US$ Million) & (2018-2023)
5.3.5 Glenmark Recent Developments
5.4 Glenmark
5.4.1 Glenmark Profile
5.4.2 Glenmark Main Business
5.4.3 Glenmark Malaria Treatment Products, Services and Solutions
5.4.4 Glenmark Malaria Treatment Revenue (US$ Million) & (2018-2023)
5.4.5 Glenmark Recent Developments
5.5 Olympus Corporation
5.5.1 Olympus Corporation Profile
5.5.2 Olympus Corporation Main Business
5.5.3 Olympus Corporation Malaria Treatment Products, Services and Solutions
5.5.4 Olympus Corporation Malaria Treatment Revenue (US$ Million) & (2018-2023)
5.5.5 Olympus Corporation Recent Developments
5.6 Abbott
5.6.1 Abbott Profile
5.6.2 Abbott Main Business
5.6.3 Abbott Malaria Treatment Products, Services and Solutions
5.6.4 Abbott Malaria Treatment Revenue (US$ Million) & (2018-2023)
5.6.5 Abbott Recent Developments
5.7 Sanofi
5.7.1 Sanofi Profile
5.7.2 Sanofi Main Business
5.7.3 Sanofi Malaria Treatment Products, Services and Solutions
5.7.4 Sanofi Malaria Treatment Revenue (US$ Million) & (2018-2023)
5.7.5 Sanofi Recent Developments
5.8 GlaxoSmithKline plc.
5.8.1 GlaxoSmithKline plc. Profile
5.8.2 GlaxoSmithKline plc. Main Business
5.8.3 GlaxoSmithKline plc. Malaria Treatment Products, Services and Solutions
5.8.4 GlaxoSmithKline plc. Malaria Treatment Revenue (US$ Million) & (2018-2023)
5.8.5 GlaxoSmithKline plc. Recent Developments
5.9 Novartis AG
5.9.1 Novartis AG Profile
5.9.2 Novartis AG Main Business
5.9.3 Novartis AG Malaria Treatment Products, Services and Solutions
5.9.4 Novartis AG Malaria Treatment Revenue (US$ Million) & (2018-2023)
5.9.5 Novartis AG Recent Developments
5.10 TEVA PHARMACEUTICAL INDUSTRIES LTD
5.10.1 TEVA PHARMACEUTICAL INDUSTRIES LTD Profile
5.10.2 TEVA PHARMACEUTICAL INDUSTRIES LTD Main Business
5.10.3 TEVA PHARMACEUTICAL INDUSTRIES LTD Malaria Treatment Products, Services and Solutions
5.10.4 TEVA PHARMACEUTICAL INDUSTRIES LTD Malaria Treatment Revenue (US$ Million) & (2018-2023)
5.10.5 TEVA PHARMACEUTICAL INDUSTRIES LTD Recent Developments
6 North America
6.1 North America Malaria Treatment Market Size by Country (2018-2029)
6.2 United States
6.3 Canada
7 Europe
7.1 Europe Malaria Treatment Market Size by Country (2018-2029)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific Malaria Treatment Market Size by Region (2018-2029)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America Malaria Treatment Market Size by Country (2018-2029)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa Malaria Treatment Market Size by Country (2018-2029)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 Malaria Treatment Market Dynamics
11.1 Malaria Treatment Industry Trends
11.2 Malaria Treatment Market Drivers
11.3 Malaria Treatment Market Challenges
11.4 Malaria Treatment Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List

Published By : QY Research

Why ‘The Market Reports’

In Business: Pre Sales Support: Post Sales Support: Turn Around Time: Clients Served: Clients Assisted: Client Types: Payment: Partners with: Number of reports: Custom Research: Report Availability: Report Delivery Format: Security:

Payments Accepted From

Connect with us at

Complete Secure Website

SiteLock